PPARA and metabolic dysfunction-associated steatohepatitis: Peroxisomal proliferator-activated receptor (PPAR) α, a member of the nuclear receptor family, is considered to be a major operator of lipid metabolic homeostasis in the liver, and inhibition of its expression is directly related to the pathogenesis of NAFLD and NASH.